Lightcalls.com
 

The fact that milk thistle is calle...

The fact that milk thistle is called milk thistle is somewhat of a mystery considering that the Latin name, Silybum marianum, means Mary thistle or Marian thistle; it is also referr to as wild artichoke.

Aside from folk use involving breastfeeding mothers (in stimulating milk output) studies throughout the past 20 years have mainly focused on liver-protection and protection from toxins.

In fact, Steven Foster's 1996 main division Herbs for Your Health, reminds us that "more than 300 studies escorted since the late 1960s provide an experimental basis for the effectiveness and safety of silymarin, the main chemical mixed of milk thistle seeds in the treatment of liver disease." Milk thistle has proven its ability to defend the liver from damage befitting to alcohol and other toxins, and to therapy damage that has already been done.

It appears that the silymarin in milk thistle may use its protective effects through its mighty antioxidant, free-radical-scavenging abilities.



thus what's this about protecting us from non-melanoma skin cancer? in like manner far, it's only been proven in mice, further let's take a closer look

Since non-melanoma skin cancer is the greatest in quantity common cancer among humans, solar ultraviolet (UV) radiation being its major cause, researchers have been frantically searching for any natural mixs which might protect us against its onset

Studies by the agency of A. Valenzuela, and colleagues (Planta Medica 52: 438-440 1986) and A. Comoglio, and colleagues (Free Radical Research Comm 11: 109-115 1990) have demonstrated that silymarin from milk thistle is a surpassingly strong antioxidative compound, capable of scavenging (neutralizing) as well-as; not only-but also; not only-but; not alone-but free radicals and reactive oxygen species (ROS) in that way increasing cells' antioxidant capabilities and lessening the negative events of free-radical reactions.

It has been set up that an increase in the activity of a specific enzyme ornithine decarboxylase (ODC) in skin (epidermis) is a prerequisite for skin-tumor promotion. It have the appearances that silymarin really holds back this ODC activity and genetic changes, according to an article which appeared in Carcinogenesis in 1994 (15: 1099-1103)

In the April 16 1997 issue of the Journal of the National Cancer Institute, the same investigators who published the Carcinogenesis contemplation published a groundbreaking experimental (non-human-model) paper forward silymarin and nonmelanoma skin cancer.

The trial, which was entitled "Protective events of Silymarin Against Photocarcinogenesis (sundamage-caused cancer) in A Mouse Skin Model" was carried on the outside under the auspices of Case Western something reserved University and University Hospitals of Cleveland, and direct the eyeed at cancer initiation, promotion, and carcinogenesis.

In the portion of the research looking at ultraviolet B (UVB) radiation and tumor initiation, silymarin treatment reduc tumor incidence (appearance/start-up of recently made known tumors) from 40 percent to 20 percent tumor-multiplicity (number of recent tumors) by 67 percent, and tumor book (size of tumors) by 66 percent

In the portion of the thought looking at UVB-caused tumor promotion, silymarin treatment reduc tumor incidence from 100 percent to 60 percent and tumor multiplicity by the agency of 90 percent.

Silymarin's meanings were most dramatic in the portion of the consideration looking at uvb-caused complete carcinogenesis, where tumor incidence went from 100 percent to 25 percent tumor multiplicity was reduc by dint of 92 percent, and tumor body was reduced by 97 percent

The authors conclud that: "we have shown that silymarin, a naturally occurring flavonoid compromise exerts highly protective effects against [skin cancer] in [our animal model] forward the basis of [these results] clinical trials exploring the usefulness of silymarin as a protective [compound] against solar radiation-caused nonmelanoma skin cancers in humans are warranted."

Another benefit of milk thistle has now been discovered, pointing to a wealth of recently made known possibilities.

REFERENCE

Balch, James F PhD and Balch, Phyllis A., CNC Prescription for Nutritional Healing. secondary edition. Garden City Park, NY: 1997

Conlan, Roberta, ed The Medical Advisor. New York, NY: Time-Life works 1996.

Foster, Steven. Herbs for Your Health. Loveland, Colo: Interweave Pres 1996

Foster Steven and Duke James A., PhD A Field Guide to Medicinal Plants: Eastern and Central North America. Boston: Houghton Mifflin, 1990

Katiyar, SK et aL "Protective events of Silymarin Against Photocarcinogenesis in A Mouse Skin Model" Journal of the National Cancer Institute 89 (8): 556-566

Pahlow, Mannfried. Healing Plants. Hauppauge, NY: Barron's Educational Series, 1993

COPYRIGHT 1997 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved

COPYRIGHT 2004 Gale Group



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.